Le Lézard
Classified in: Health
Subjects: PDT, WOM, SCZ

InventHelp Inventor Develops Incontinence Underwear for Women (AAT-3067)


PITTSBURGH, June 18, 2018 /PRNewswire/ -- An inventor from Snellville, Ga., has developed the FREE FORM, improved underwear designed to provide added comfort, confidence and peace of mind for women who experience urinary incontinence.

InventHelp Logo (PRNewsfoto/InventHelp)

"I developed my invention due to my own need. I was inspired to develop a pair of underwear that would absorb leaks and discharge, as well as not soil clothes," said the inventor. The FREE FORM provides women who suffer with incontinence with a feeling of normalcy. It offers a more comfortable and aesthetic alternative to various incontinence products. This will eliminate the embarrassment of purchasing disposable incontinence products, as well as reduce the expense associated with purchasing panty liners. This undergarment will provide women with protection from embarrassing spots or stains. It has a discreet design and is comfortable to wear.

The original design was submitted to the Atlanta office of InventHelp. It is currently available for licensing or sale to manufacturers or marketers. For more information, write Dept. 17-AAT-3067, InventHelp, 217 Ninth Street, Pittsburgh, PA 15222, or call (412) 288-1300 ext. 1368. Learn more about InventHelp's Invention Submission Services at http://www.InventHelp.com.

 

SOURCE InventHelp


These press releases may also interest you

at 04:00
Bioforum the Data Masters Introduces SUBMIT24: A Free of Charge and Revolutionary CDISC CORE-Based Clinical Data Validation Tool
Bioforum, the Data Masters, a leading contract research organization (CRO) focused on the delivery of biometric services and solutions to the global clinical trials industry, today announced the launch of SUBMIT24 in its beta version during Q3 2024,...

at 04:00
TVM Capital Healthcare Announces US$ 17 Million Investment into neurocare
TVM Capital Healthcare, a specialist healthcare private equity firm headquartered in Dubai and...

at 03:26
Calliditas Announces Positive NefIgArd Open Label Extension Results
Calliditas Therapeutics AB , ("Calliditas") today announced that the global open-label extension (OLE) study to the Phase 3 NefIgArd study showed a treatment response consistent with the NefIgArd study across endpoints of urine protein to creatinine...

at 03:00
Precision oncology company Flindr Therapeutics announces ?20 million Series A financing to advance first-in-class small molecule inhibitors
Flindr...

at 03:00
CSL Vifor and Travere Therapeutics Announce European Commission approves FILSPARI® (sparsentan) for the treatment of IgA Nephropathy
CSL Vifor and Travere Therapeutics, Inc., today announced that the European Commission has granted conditional marketing authorization (CMA) for FILSPARI (sparsentan) for the...

at 03:00
Tetra Pharm Technologies and Glysious Announce Collaboration to Develop Transdermal Combination Drugs Targeting the Endocannabinoid System
Tetra Pharm Technologies and Glysious are pleased to announce a strategic collaboration aimed at developing a ground-breaking transdermal drug delivery system complementing several of Tetra Pharm Technologies' pipeline candidates. The...

More news about Health...


News published on and distributed by: